Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
Sotorasib is indicated for adults with KRAS G12C-mutated,previously treated locally advanced or metastatic non-small cell lung cancer,commonly 960 mg once daily,swallowed whole with or without food.Diarrhea is among the most frequent gastrointestinal adverse events.In a pooled CodeBreaK analysis of 549 patients,treatment-related diarrhea occurred in 31.1%,mostly low grade;more than 90%of diarrhea events resolved after dose interruption or reduction,with median resolution around 18–22 days.Most cases begin early in treatment,but severity—not just stool count—should guide management.
1)Onset and grading
Mild diarrhea means several loose stools without dehydration or significant functional impact.Moderate-to-severe diarrhea limits oral intake,sleep or daily activity.More than 6 watery stools per day,dizziness,scanty urine,fever,abdominal pain or bloody stools is not routine drug-related diarrhea and requires medical review.
2)Home antidiarrheal care
After the first loose stool,loperamide may be used as directed by the oncologist or product leaflet.A common adult schedule is 4 mg initially,then 2 mg after each subsequent loose stool;the 24-hour maximum depends on the local product,with many references allowing up to 16 mg and some cancer protocols limiting to 8 mg.Stop loperamide about 12 hours after stools normalize to avoid constipation.Do not use loperamide alone when there is high fever,bloody diarrhea,severe abdominal pain or suspected infection;obtain stool testing instead.
3)Rehydration and diet
Use oral rehydration salts in small,frequent amounts.Unless fluids are restricted,maintain adequate intake and monitor urine output,thirst and mucous membranes.Favor rice porridge,noodles,bananas,applesauce and toast;avoid dairy,raw or greasy foods,spice,caffeine and high-fiber produce during active diarrhea.Keep a daily log of stool frequency,consistency,urine output and weight to support grading at follow-up.
4)Urgent warning signs
Seek immediate care for more than 6 diarrheal episodes per day,or any combination of dehydration signs such as dry mouth,dizziness and reduced urine;fever or chills;blood or black stools;uncontrolled abdominal pain;poor response to loperamide;or marked weakness.Hold sotorasib and evaluate electrolytes,renal function and stool pathogens;intravenous fluids may be needed.New or worsening shortness of breath with cough should prompt separate assessment for interstitial lung disease.
5)Dose modification
Grade 1 diarrhea usually continues with symptomatic care.Recurrent grade 2 or higher,or any diarrhea that affects daily life,should be managed by the oncology team with temporary hold,dose reduction or restart.For sotorasib monotherapy,standard reductions are 480 mg once daily first,then 240 mg once daily;discontinue if the minimum dose is not tolerable.Do not self-restart at the original dose.Monitor liver enzymes,electrolytes and nutritional status throughout therapy.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)